Video | July 12, 2021

How A Surgeon Came To Be A Biopharma CEO

Source: Life Science Leader

In this executive virtual roundtable (EVR) segment, Roger Crystal, M.D., president and CEO of Opiant Pharmaceuticals, a biopharma focused on the treatment of addiction and drug overdose, explains how he, a surgeon, came to be the CEO of Opiant 10 years ago, albeit initially part-time.

View the full presentation here.